Experimental hepatitis b vaccines pass early safety check

NCT ID NCT05770895

First seen Feb 01, 2026 · Last updated May 13, 2026 · Updated 18 times

Summary

This early-stage study tested two experimental vaccines, GS-2829 and GS-6779, in 83 healthy volunteers and people with chronic hepatitis B. The main goal was to see if the vaccines were safe and tolerable. Researchers also looked for signs that the vaccines boosted the immune system's ability to fight the hepatitis B virus.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 833, Taiwan

  • Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital

    Taoyuan City, 33305, Taiwan

  • Chia-Yi Christian Hospital

    Chiayi City, 60002, Taiwan

  • E-DA Hospital

    Kaohsiung City, 82445, Taiwan

  • Kaohsiung Medical University Hospital

    Kaohsiung City, 807, Taiwan

  • National Cheng Kung University Hospital

    Tainan, 7428, Taiwan

  • National Taiwan University Hospital

    Taipei, 100229, Taiwan

  • New Zealand Clinical Research (NZCR)

    Auckland, 1010, New Zealand

  • St. Martin De Porres Hospital

    Chiayi City, 600, Taiwan

Conditions

Explore the condition pages connected to this study.